Invivyd Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-206.82	-198.64	-241.32	-226.79	-111.98
Depreciation & Amortization	2.05	2.03	0.46	0	-
Asset Writedown & Restructuring Costs	-	-	-	-	68.43
Loss (Gain) From Sale of Investments	1.42	-1.12	-2.02	1.43	-
Stock-Based Compensation	18.66	18.69	21.65	17.76	0.27
Other Operating Activities	-	-	17.37	0.07	-
Change in Inventory	-0.1	-	-	-	-
Change in Accounts Payable	-4.74	6.47	-4.3	-2.37	13.98
Change in Other Net Operating Assets	7.33	-0.58	-11.83	25.16	4.33
Operating Cash Flow	-182.2	-173.16	-219.99	-184.74	-24.98
Capital Expenditures	-0.13	-0.62	-1.71	-0.08	-
Investment in Securities	205.64	281.3	-228.96	-50.63	-
Investing Cash Flow	205.51	280.68	-230.67	-50.71	-
Issuance of Common Stock	40.03	1.2	0.51	330.91	0.02
Repurchase of Common Stock	-0	-0	-0	-	-0.01
Other Financing Activities	-0.42	-0.15	-	-3.39	-
Financing Cash Flow	39.6	1.05	0.51	662.68	222.1
Net Cash Flow	62.92	108.57	-450.15	427.24	197.12
Free Cash Flow	-182.33	-173.78	-221.69	-184.82	-24.98
Free Cash Flow Per Share	-1.64	-1.59	-2.05	-4.34	-6.92
Levered Free Cash Flow	-108.64	-103.6	-139.23	-93.29	-
Unlevered Free Cash Flow	-108.64	-103.6	-139.23	-93.29	-
Change in Net Working Capital	-5.44	-6.06	18.22	-26.09	-

Source: S&P Capital IQ. Standard template.